Lilly to Close Singapore Discovery Center



















BYE·BYE·EMPIRE·EMPIRE·BYE·BYE

Erl Wood, Alcobendas, San Diego, Imclone NYC Protein Palace--in that order. Rolling waves of layoffs/closures as the headcount cuts accelerate beyond 5500. "Unexpected" early patent losses/invalidations, more ligitation/fines, greater revenue loss...
 






Re: BYE·BYE·EMPIRE·EMPIRE·BYE·BYE

Erl Wood, Alcobendas, San Diego, Imclone NYC Protein Palace--in that order. Rolling waves of layoffs/closures as the headcount cuts accelerate beyond 5500. "Unexpected" early patent losses/invalidations, more ligitation/fines, greater revenue loss...

Some of those let go by Leichleiter can go work for Jeffrey Immelt at GE. Now there is one smart CEO. He says that workers in 'other countries' do not have the same kind of quality output that American workers provide, so he creates 550 American jobs - and collects a large federal tax credit.

Now THAT is a CEO that has my vote, and the employees' vote, and the stockholder's vote and with that kind of combination of economic and political finesse, heck he could probably pick up the presidency of the US. Would you vote for him?
 






Re: BYE·BYE·EMPIRE·EMPIRE·BYE·BYE

Some of those let go by Leichleiter can go work for Jeffrey Immelt at GE. Now there is one smart CEO. He says that workers in 'other countries' do not have the same kind of quality output that American workers provide, so he creates 550 American jobs - and collects a large federal tax credit.

Now THAT is a CEO that has my vote, and the employees' vote, and the stockholder's vote and with that kind of combination of economic and political finesse, heck he could probably pick up the presidency of the US. Would you vote for him?

Why yes, I would. I hear he makes a mean wind-propeller-thingy, and an awesome sandwich! J¢£
 






Re: Sell it all off

FIPNET calls for Everything except for senior management, the strategy group, and the board of directors to be owned and ran by a third party. It will cost Lilly a lot more money, but management and the BOD will all make a ton of money along the way.

Cut headcount. Cut salaries. All US and OUS global sites are on the block. No exceptions.

Senior management and strategy can be contracted out, too. All that will remain is the Board and the Brand. Expect corporation move to China to avoid US taxes. No one seems concerned about the risk to IP or patient privacy.
 






LLY SHELL CORPSE

Senior management and strategy can be contracted out, too. All that will remain is the Board and the Brand. Expect corporation move to China to avoid US taxes. No one seems concerned about the risk to IP or patient privacy.

All that will remain is a shell corporation--a PO box to send subpoenas to. Address them to:
LCSO (Lechleiter Corporate Shell Officer)
Lilly Corporate Center
Dropcode 1
Indianapolis, IN 46285
 




































The Lisping Drones


"In China, Lilly has not built its own R&D facility, but has stressed partnerships with local companies. Tony Zhang, Head of Lilly’s China R&D operation, says that the company’s R&D model is FIPNET, a fully integrated pharmaceutical network based on partnerships, not a FIPCO, a fully integrated pharmaceutical company."

With mindless, lisping half-wits like this, spewing the idiocy du jour, it is sure to fail fast. Sell Now!
 






Seems like JCL and coterie is waist deep into buying the argument that antibody treatment for everything. Perhaps. More likely not, if you look at how data is interpreted. Idiot!
 






Seems like JCL and coterie is waist deep into buying the argument that antibody treatment for everything. Perhaps. More likely not, if you look at how data is interpreted. Idiot!

Even the specificity of antibodies for relatively small molecules is quite low. Antibodies may be great for research, or industrial processes - but outside of those produced by our own bodies under normal circumstances, I certainly would not want my life to depend upon them.
 






Antibody Spree

I will get all $6billion of value from my super-astute acquisition of MarthaClone, and with injectable Antibody goodness we will weather the Looming Patent Cliff with my Imaginary PipeLie! Emperor £udwig£eiter
 






Most of you are missing the point. Sedgwick ran another group of researchers into the ground just as he did in Indianapolis. Think he'll be laid off? Ask anyone in his old DHT.
 






Most of you are missing the point. Sedgwick ran another group of researchers into the ground just as he did in Indianapolis. Think he'll be laid off? Ask anyone in his old DHT.

Well maybe we are all missing the point. True researchers will find a very hostile working environment at Lilly. There are no strong managers to defend the geek crowd, except maybe for some Asian triads in which much larger, invisible transactions are conducted in exchange for long hours and intellectual property transfer. For American research scientists, this is not the place to be, regardless of who your director might be. The company is run by someone who was hired as a "Senior Research Scientist" who does not have a single research success to speak of - if you know of any, I sure would love to know.